These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

230 related items for PubMed ID: 29905398

  • 21. Single-dose rasburicase 6 mg in the management of tumor lysis syndrome in adults.
    McDonnell AM, Lenz KL, Frei-Lahr DA, Hayslip J, Hall PD.
    Pharmacotherapy; 2006 Jun; 26(6):806-12. PubMed ID: 16716134
    [Abstract] [Full Text] [Related]

  • 22. Assessment of rasburicase utilization for tumor lysis syndrome management in pediatric and adult patients in the inpatient and outpatient settings.
    Abousaud MI, Rush MC, Rockey M.
    J Oncol Pharm Pract; 2021 Jul; 27(5):1165-1171. PubMed ID: 32727320
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. More to rasburicase than uric Acid.
    Patel S, Le AN.
    Pharmacotherapy; 2013 Sep; 33(9):e177. PubMed ID: 23744455
    [No Abstract] [Full Text] [Related]

  • 26. Efficacy of Single Low-Dose Rasburicase in Management of Tumor Lysis Syndrome in Leukemia and Lymphoma Patients.
    Gupta G, Seth T, Garg V, Juneja R, Mahapatra M, Datta SK, Upadhyay AD, Saxena R.
    Clin Lymphoma Myeloma Leuk; 2021 Jan; 21(1):e99-e104. PubMed ID: 33039358
    [Abstract] [Full Text] [Related]

  • 27. Efficacy of rasburicase (recombinant urate oxidase) in the prevention and treatment of malignancy-associated hyperuricemia: an Indian experience.
    Digumarti R, Sinha S, Nirni SS, Patil SG, Pedapenki RM.
    Indian J Cancer; 2014 Jan; 51(2):180-3. PubMed ID: 25104205
    [Abstract] [Full Text] [Related]

  • 28. A retrospective observational study of a low fixed-dose rasburicase protocol for the treatment of tumor lysis syndrome in adults.
    Hossain S, Naber M, Yacobucci MJ.
    J Oncol Pharm Pract; 2022 Sep; 28(6):1326-1331. PubMed ID: 34115548
    [Abstract] [Full Text] [Related]

  • 29. Rasburicase in cancer-related hyperuricemia.
    Rodriguez M, Campara M, Haaf C.
    Drugs Today (Barc); 2011 Aug; 47(8):591-603. PubMed ID: 21850282
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A study of rasburicase for the management of hyperuricemia in pediatric patients with newly diagnosed hematologic malignancies at high risk for tumor lysis syndrome.
    Kikuchi A, Kigasawa H, Tsurusawa M, Kawa K, Kikuta A, Tsuchida M, Nagatoshi Y, Asami K, Horibe K, Makimoto A, Tsukimoto I.
    Int J Hematol; 2009 Nov; 90(4):492-500. PubMed ID: 19701676
    [Abstract] [Full Text] [Related]

  • 32. Single-Dose Rasburicase Might Be Adequate To Overcome Tumor Lysis Syndrome In Hematological Malignancies.
    Yaman S, Başcı S, Turan G, Ulu BU, Yiğenoğlu TN, Dal MS, Kızıl Çakar M, Altuntaş F.
    Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):e71-e76. PubMed ID: 34565690
    [Abstract] [Full Text] [Related]

  • 33. Low-dose rasburicase in hematologic malignancies.
    Jayabose S, Kumar V, Dhanabalan R, Rajan P, Rathnam K, Viswanathan TK.
    Indian J Pediatr; 2015 May; 82(5):458-61. PubMed ID: 25338496
    [Abstract] [Full Text] [Related]

  • 34. Managing malignancy-associated hyperuricemia with rasburicase.
    Cheson BD, Dutcher BS.
    J Support Oncol; 2005 May; 3(2):117-24. PubMed ID: 15796443
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Reduced-dose rasburicase (recombinant xanthine oxidase) in adult cancer patients with hyperuricemia.
    Trifilio S, Gordon L, Singhal S, Tallman M, Evens A, Rashid K, Fishman M, Masino K, Pi J, Mehta J.
    Bone Marrow Transplant; 2006 Jun; 37(11):997-1001. PubMed ID: 16708061
    [Abstract] [Full Text] [Related]

  • 39. Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout.
    Cammalleri L, Malaguarnera M.
    Int J Med Sci; 2007 Mar 02; 4(2):83-93. PubMed ID: 17396159
    [Abstract] [Full Text] [Related]

  • 40. Evaluation of a single fixed dose of rasburicase 7.5 mg for the treatment of hyperuricemia in adults with cancer.
    Reeves DJ, Bestul DJ.
    Pharmacotherapy; 2008 Jun 02; 28(6):685-90. PubMed ID: 18503395
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.